Search Results

Displaying Results 1351-1375 of 2868 "'LI'"

Mar 20, 2026, 14:40 ET U Power Limited Announces Closing of $6.0 Million Public Offering

$6.0 million.Maxim Group LLC acted as the exclusive underwriter for the Offering. Hunter Taubman Fischer & Li LLC served as U.S. securities counsel to the Company and Ellenoff Grossman & Schole LLP served as U.S. securities counsel to the underwriter.The

More news about: U Power Limited


Mar 20, 2026, 12:14 ET TCL integra los criterios ESG para generar un impacto positivo en toda la cadena de valor global

globalLi Dongsheng, fundador y presidente de TCL, en un diálogo en profundidad con el Pacto Mundial de las Naciones UnidasSHENZHEN, China, 20 de marzo de 2026 /PRNewswire/ -- Li Dongsheng, fundador y presidente

More news about: TCL


Mar 20, 2026, 10:35 ET Arcfra AECP 6.3 phá vỡ rào cản IOPS 11M, mang lại hiệu năng All-Flash cấp Tier 1 và khả năng phục hồi RPO=0 cho dịch vụ đám mây doanh nghiệp

kiến trúc hệ thống."Năm 2026, tiêu chí đối với ảo hóa đã chuyển từ 'có thể vận hành' sang 'có thể vận hành hiệu quả và bền vững'", Robert Li, Giám đốc Liên minh và Tiếp thị Sản phẩm tại Arcfra cho biết. "AECP 6.3 đánh dấu việc hạ tầng siêu hội tụ bước vào kỷ nguyên tăng tốc lấy AI làm nền

More news about: Arcfra


Mar 20, 2026, 10:34 ET Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026

waters."The launch of these two new products underscores Angel's ongoing advances in fermentation technology and advanced enzymatic hydrolysis," said Li Ku, General Manager of Angel's Protein Nutrition and Flavoring Technology Center. "We are also developing functional yeast proteins with high gelation

More news about: Angel Yeast


Mar 20, 2026, 10:29 ET 아크프라 AECP 6.3, 1100만 IOPS 장벽 돌파… 엔터프라이즈 클라우드를 위한 티어-1 올플래시 성능과 RPO=0 복원력 제공

기업들이 급등하는 라이선스 비용과 대규모 AI 데이터 볼륨 처리의 필요성에 직면하는 가운데, AECP 6.3은 심층적인 아키텍처 최적화를 통해 고가의 독점 스토리지에 대한 요구를 없앤다.아크프라 얼라이언스 및 제품 마케팅 부문의 로버트 리(Robert Li) 디렉터는 "2026년에는 가상화의 기준이 '실행 가능한가'에서 '효율적이고 지속 가능하게 실행 가능한가'로 이동했다"고 말했다. 이어 "AECP 6.3은 하이퍼컨버지드 인프라가 네이티브 AI 가속의 시대로 진입하는 것을 의미하며, 레거시 시스템에서 마이그레이션할 때

More news about: Arcfra


Mar 20, 2026, 10:22 ET Quality Protein No Longer a Luxury? Angel Yeast Shows How at FIC 2026

waters."The launch of these two new products underscores Angel's ongoing advances in fermentation technology and advanced enzymatic hydrolysis," said Li Ku, General Manager of Angel's Protein Nutrition and Flavoring Technology Center. "We are also developing functional yeast proteins with high gelation

More news about: Angel Yeast


Mar 20, 2026, 10:21 ET TCL is a "Doer": Embedding ESG to Create Positive Impact across the Global Value Chain

TCL Founder and Chairman Li Dongsheng in an In-Depth Dialogue with the United Nations Global CompactSHENZHEN, China, March 20, 2026 /PRNewswire/ -- TCL Founder and Chairman Li Dongsheng recently participated in

More news about: TCL


Mar 20, 2026, 10:08 ET TCL is a "Doer": Embedding ESG to Create Positive Impact across the Global Value Chain

TCL Founder and Chairman Li Dongsheng in an In-Depth Dialogue with the United Nations Global CompactSHENZHEN, China, March 20, 2026 /PRNewswire/ -- TCL Founder and Chairman Li Dongsheng recently participated in

More news about: TCL


Mar 20, 2026, 03:25 ET Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair

History: Book Launch on the Works with Cultural Heritage, which explored innovative modern expressions of cultural heritage.Chinese author Li Shanshan shared insights into the creation of her Sanxingdui-inspired work The Millennial Vessel.Together with Manon Steffan Ros, winner

More news about: China National Publications Import and Export (Group) Co., Ltd


Mar 20, 2026, 03:13 ET Chinese Publishing Industry Showcases Global Vision and Forges Deeper Ties at 2026 London Book Fair

History: Book Launch on the Works with Cultural Heritage, which explored innovative modern expressions of cultural heritage.Chinese author Li Shanshan shared insights into the creation of her Sanxingdui-inspired work The Millennial Vessel.Together with Manon Steffan Ros, winner

More news about: China National Publications Import and Export (Group) Co., Ltd


Mar 20, 2026, 02:06 ET Arcfra AECP 6.3 Breaks the 11M IOPS Barrier, Delivering Tier-1 All-Flash Performance and RPO=0 Resilience for Enterprise Cloud

optimization."In 2026, the criteria for virtualization has shifted from 'can it run' to 'can it run efficiently and sustainably,'" said Robert Li, Director of Alliance and Product Marketing at Arcfra. "AECP 6.3 marks the entry of hyperconverged infrastructure into the era of native AI acceleration,

More news about: Arcfra


Mar 19, 2026, 22:36 ET Chiayi International Art Doc Film Festival 2026: A Global Intersection of Land Art and AI Ethics

atmosphere."Environmental Language and Global PerspectivesThe "Environmental Art Trend Forum" challenged gallery norms. Taiwanese artists Li Kuei-Chih and Lin Chun-Yung, with Mexico's Lua Rivera, argued that art must move beyond "white cube" spaces to become a "cross-species language" in daily

More news about: Chiayi International Art Doc Film Festival


Mar 19, 2026, 14:47 ET DISTINGUISHED GUEST SPEAKERS TO JOIN SEABOURN CONVERSATIONS ON 2027 WORLD CRUISE

27-Day World Cruise: South Pacific Isles & New ZealandLi Cunxin & Mary LiLi Cunxin is a Chinese-Australian former ballet dancer; after studying at Houston Ballet School, he made headlines by defecting to the West

More news about: Seabourn


Mar 19, 2026, 08:10 ET Ractigen Therapeutics Announces China NMPA IND Approval for Phase II Clinical Trial of saRNA Therapy RAG-01 in Non-Muscle Invasive Bladder Cancer

response (CR) signals."We are very pleased to receive IND approval from the China NMPA CDE for the Phase II trial of RAG-01," said Dr. Long-Cheng Li, Founder and CEO of Ractigen Therapeutics. "This approval is an important validation of both the RAG-01 program and the broader potential of saRNA

More news about: Ractigen Therapeutics


Mar 19, 2026, 04:05 ET UP Fintech: Record Full-Year Revenue and Profit; Full-Year Profit Surges 165% YoY; Global Client Assets Reach US$60.8 Billion

high-quality corporate ecosystem. During Q4, the platform also livestreamed several major corporate events, including Leapmotor's 10th anniversary event, Li Auto's LiviS AI glasses launch and earnings call, and Faraday Future's FX Super One Middle East global launch, further enhancing the platform's influence

More news about: UP Fintech Holding Limited


Mar 18, 2026, 18:00 ET Kubit Integrates with Snowflake to Deliver Warehouse-Native Product Analytics in the Snowflake AI Data Cloud

lifetime value—using a single, governed data foundation."We built Kubit to help organizations move faster with analytics they can trust," said Alex Li, Founder and CEO, Kubit. "By running directly in the Snowflake AI Data Cloud, we deliver warehouse-native digital analytics and explainable AI on governed

More news about: Kubit


Mar 18, 2026, 17:00 ET Widest Caesium Drill Intercept to Date at the Helios Caesium Zone in Final Batch of 2025 Drill Results from Shaakichiuwaanaan

Inferred, and is reported at a cut-off grade of 0.40% Li2O (open-pit), 0.60% Li2O (underground CV5), and 0.70% Li2O (underground CV13). A grade constraint of 0.50% Cs

More news about: PMET Resources Inc.


Mar 18, 2026, 11:22 ET 總生存期顯著延長:蘆康沙妥珠單抗(sac-TMT) OptiTROP-Lung03研究OS最終分析結果亮相

專案處於NDA階段,10餘個專案正處於臨床階段。公司成功構建了享譽國際的專有ADC及新型偶聯藥物平臺OptiDCTM,已有2個ADC項目5個適應症獲批上市,多個ADC或新型偶聯藥物產品處於臨床或臨床前研究階段。參考來源:[1] Fang W, Li X, Wang Q, et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutant advanced non-small-cell lung cancer: open label, randomised,

More news about: 科倫博泰


Mar 18, 2026, 10:27 ET Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study

Reference:[1] Fang W, Li X, Wang Q, et al. Sacituzumab tirumotecan versus docetaxel for previously treated EGFR-mutant advanced non-small-cell lung cancer: open label, randomised,

More news about: Kelun-Biotech


Mar 18, 2026, 08:00 ET TDH Holdings, Inc. Announces Receipt of Nasdaq Notice Regarding Board and Audit Committee Composition Requirements

continue to trade uninterrupted on Nasdaq under the ticker "PETZ." On March 11, 2026, the Company notified Nasdaq that, due to the resignation of Qiu Li from the Company's Board and its committees effective as of March 11, 2026, the Company was no longer in compliance with Nasdaq Listing Rule 5605(b)(1),

More news about: TDH Holdings, Inc.


Mar 18, 2026, 03:30 ET GoStudent - Crisi dell'istruzione: tra studenti esausti, annoiati e dipendenti dai social media, il 90%[1] mostra sintomi d'ansia

di percezione tra le mura domestiche e l'aula.Mentre in Italia il 69% dei genitori intervistati ritiene i figli motivati e il 51% li considera sopra la media, il 54% dei docenti europei intervistati segnala un declino della motivazione negli ultimi due anni. Anche l'offerta

More news about: GoStudent


Mar 17, 2026, 21:30 ET Innorna annonce la désignation par la FDA de nouveau médicament de recherche pour IN026, faisant progresser les thérapies basées sur l'ARNm dans les maladies métaboliques chroniques

l'ARNm, en tant que nouvelle modalité, peut permettre ce que les approches thérapeutiques existantes ne peuvent pas faire », a déclaré le Dr Linxian Li, fondateur et PDG d'Innorna. « Avec l'entrée en phase de développement clinique d'IN026, nous ouvrons un nouveau chapitre pour les thérapies de remplacement

More news about: Innorna Co., Ltd.


Mar 17, 2026, 21:26 ET Innorna gibt die Genehmigung des IND-Antrags für IN026 durch die FDA bekannt und treibt damit die Entwicklung von mRNA-basierten Therapien für chronische Stoffwechselerkrankungen voran

Überzeugung gegründet, dass mRNA als neue Modalität das erreichen kann, was bestehende therapeutische Ansätze nicht leisten können", sagte Dr. Linxian Li, Gründer und CEO von Innorna. „Mit dem Eintritt von IN026 in die klinische Entwicklung schlagen wir ein neues Kapitel für mRNA-basierte Proteinersatztherapien

More news about: Innorna Co., Ltd.


Mar 17, 2026, 20:54 ET Innorna anuncia la aprobación de la FDA de IND para IN026

con la convicción de que el ARNm, como nueva modalidad, puede lograr lo que los enfoques terapéuticos actuales no pueden", afirmó el doctor Linxian Li, fundador y consejero delegado de Innorna. "Con el avance de IN026 al desarrollo clínico, estamos abriendo un nuevo capítulo en las terapias de reemplazo

More news about: Innorna Co., Ltd.


Mar 17, 2026, 20:02 ET Video Rebirth Secures $80 Million to Build the World's First Industrial-Grade AI Engine

between linear media and interactive entertainment."We are at the precipice of a 'De-engineering' revolution in pan-entertainment" said Difu Li, Co-founder and CSO, formerly leading the AI strategy at Tencent. "By mastering the causal logic and high-fidelity persistence of generative video today,

More news about: Video Rebirth


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.